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Although antitumor drugs such as DNA synthesis inhibitors and antimitotic agents (microtubule modulators) have played important roles in the cancer chemotherapy, their clinical use is limited by their side effects. Thus, the continuing screening efforts have been made to discover more effective antitumor drugs.
In the previous paper1}, we have reported that a novel antimitotic substance, FR182877 isolated from the fermentation broth of Streptomyces sp. No. 9885, was discovered by developing a new screening method for antimitotic substances (Fig. 1) . In this note, we describe the effect of FR182877 on the cell cycle transition and the microtubule assembly in vitro as the mechanism of action ofFR182877.
The phase studies of FR182877 on the cell cycle distribution of HT-29 cells were performed. The cells were treated with various concentration of FR182877 or known antitumor drugs and DNAcontents were analyzed by flow cytometry.
FR182877 and taxol23) induced G2/M phase arrest (Fig. 2) . In addition, other antimitotic drugs such as vincristine4) and rhizoxin5) also induced G2/Mphase arrest, In addition, the polymerization curves of tubulin incubated with FR182877
were preceded by a lag phase. The time lag period was remarkably reduced at higher concentrations of FR1 82877 tested. Further, taxol induced the assembly of tubulin, while the anti-tubulin drugs such as vincristine and rhizoxin inhibited microtubule assembly (Fig. 3) . These changes are consistent with the mechanism of action of the drugs2 7). The efficacy of FR182877 in the microtubule assembly was almost similar to that of taxol. However, the concentration of FR182877 to induce the microtubule assembly was about five to ten times higher than that of taxol. The kinetic analysis for microtubule assembly suggested involvement of more than one step of microtubule assembly; for example, a nucleation step followed by elongation or growth ofmicrotubules. Detail of the kinetic studies ofFR182877 is now in progress.
These results indicate that FR182877 promotes the microtubule assembly in vitro and induced G2/M phase arrest in the cell cycle. This mode of action represents that FR182877 is a new structural class of microtubulestabilizing agents such as taxol and epothilones8). In addition, FR182877 prolonged the life span of murine Fig. 1 . Chemical structure ofFR182877.
1 Present address:Toyo University, Faculty of Life Sciences, Itakura, Oragun, Gunma 374-0193, Japan. containing PEM buffer (80mM piperazine-TV,7V'-bis (2- ethanesulfonic acid) sesquisodium salt, 1 mMmagnesium chloride, 1 mMethylene glycol-bis(6-amino-ethyl ether) #,7V,7V' ,A^'-tetraacetic acid, adjusted to pH 6.8 with NaOH), lmM GTP and test compound were kept at room temperature before addition of tubulin (1 mg/ml at final concentration) and shifted to 35°C. FR182877 and taxol were dissolved in DMSOand stored at -20°C. The final concentration of DMSO(0.5%) had no detectable effect on the microtubule assembly.
